LifeTech Scientific Corporation released its monthly return for equity securities as of November 30, 2025. According to the announcement, the company’s total authorized share capital remained at 40,000,000,000 ordinary shares, with a par value of USD 0.00000125 each. The total authorized capital at month-end remained USD 50,000.

The number of issued shares stood at 4,631,712,400, unchanged from the previous month. No treasury shares were reported. In terms of share options, the first scheme recorded 25,590,000 options outstanding with no new shares issued. Under the second scheme, 284,785,000 options were outstanding at the start of the month, with 725,000 lapsed, leaving 284,060,000 options outstanding. No additional share issuances or other movements in issued shares were noted during the reporting period.